Two Sigma Advisers’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-120,200
| Closed | -$2.84M | – | 2691 |
|
|
2023
Q4 | $2.84M | Sell |
120,200
-547,838
| -82% | -$12.9M | 0.01% | 1089 |
|
|
2023
Q3 | $9.96M | Sell |
668,038
-488,400
| -42% | -$7.28M | 0.03% | 470 |
|
|
2023
Q2 | $12.7M | Sell |
1,156,438
-258,400
| -18% | -$2.83M | 0.03% | 424 |
|
|
2023
Q1 | $12.3M | Buy |
1,414,838
+1,011,300
| +251% | +$8.82M | 0.03% | 482 |
|
|
2022
Q4 | $2.53M | Buy |
403,538
+23,700
| +6% | +$149K | 0.01% | 1111 |
|
|
2022
Q3 | $1.33M | Buy |
379,838
+232,300
| +157% | +$813K | ﹤0.01% | 1377 |
|
|
2022
Q2 | $435K | Buy |
147,538
+20,500
| +16% | +$60.4K | ﹤0.01% | 1982 |
|
|
2022
Q1 | $395K | Sell |
127,038
-60,100
| -32% | -$187K | ﹤0.01% | 2101 |
|
|
2021
Q4 | $633K | Sell |
187,138
-196,600
| -51% | -$665K | ﹤0.01% | 1797 |
|
|
2021
Q3 | $1.4M | Sell |
383,738
-464,600
| -55% | -$1.7M | ﹤0.01% | 1450 |
|
|
2021
Q2 | $3.7M | Sell |
848,338
-469,600
| -36% | -$2.05M | 0.01% | 1005 |
|
|
2021
Q1 | $5.98M | Buy |
1,317,938
+102,500
| +8% | +$465K | 0.02% | 776 |
|
|
2020
Q4 | $6.98M | Buy |
1,215,438
+807,300
| +198% | +$4.63M | 0.02% | 702 |
|
|
2020
Q3 | $2.96M | Buy |
408,138
+35,500
| +10% | +$257K | 0.01% | 969 |
|
|
2020
Q2 | $1.3M | Buy |
372,638
+20,400
| +6% | +$71.2K | ﹤0.01% | 1449 |
|
|
2020
Q1 | $521K | Buy |
352,238
+231,000
| +191% | +$342K | ﹤0.01% | 1787 |
|
|
2019
Q4 | $238K | Buy |
+121,238
| New | +$238K | ﹤0.01% | 2129 |
|
|
2019
Q2 | – | Sell |
-21,500
| Closed | -$286K | – | 2477 |
|
|
2019
Q1 | $286K | Sell |
21,500
-2,700
| -11% | -$35.9K | ﹤0.01% | 2004 |
|
|
2018
Q4 | $190K | Sell |
24,200
-14,000
| -37% | -$110K | ﹤0.01% | 2142 |
|
|
2018
Q3 | $423K | Sell |
38,200
-26,400
| -41% | -$292K | ﹤0.01% | 1857 |
|
|
2018
Q2 | $867K | Sell |
64,600
-9,500
| -13% | -$128K | ﹤0.01% | 1674 |
|
|
2018
Q1 | $963K | Buy |
74,100
+59,500
| +408% | +$773K | ﹤0.01% | 1560 |
|
|
2017
Q4 | $134K | Buy |
14,600
+800
| +6% | +$7.34K | ﹤0.01% | 2126 |
|
|
2017
Q3 | $111K | Buy |
+13,800
| New | +$111K | ﹤0.01% | 2112 |
|